The most-cited animal studies (including work from Sikiric's group in Zagreb) used intraperitoneal or subcutaneous doses of roughly 10 mcg per kg in rats
No studies have examined whether BPC-157 use increases cancer risk, but the concern is biologically plausible
GHK-Cu, TB-500 and BPC-157 are all unapproved research chemicals, none FDA-approved for human administration [10]
Unlike oral supplements, which must pass through the digestive system, IV therapy delivers B12 directly into your bloodstream
B12 Deficiency: If there is a vitamin B12 deficiency, the starting dosage of 30mcg is administered beneath the skin or into the muscle daily for scheduled days to boost the overall levels
A synthetic peptide derived from a naturally occurring protein, BPC-157 promotes angiogenesis, improves blood flow to damaged areas, and supports healing across musculoskeletal and gastrointestinal systems at the cellular level